Home Care Settings is Expected to be the Fastest Growing Segment During the Forecast Period 2021–2028

According to a new market research study on “South America Sleep Apnea Diagnostics Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product and End User,” is expected to reach US$ 51.69 million by 2028 from US$ 38.30 million in 2021. The market is estimated to grow at a CAGR of 4.4% from 2021 to 2028. The report provides trends prevailing in the South America sleep apnea diagnostics market along with the drivers and restraints pertaining to the market growth. Expanding geriatric population advancing scope of telemedicine, and heighten technological developments are the major factor driving the growth of the South America sleep apnea diagnostics market. However, higher expenses of diagnosis of sleep apnea hinder the growth of South America sleep apnea diagnostics market.

The outbreak of COVID–19 has stringently affected medical services in the South America region. Also, the nations are famous for medical tourism, which is also influenced by the pandemic. Brazil, Argentina, Uruguay, Chile, Peru, Colombia is concerned by the second wave of corona infection. Amongst which Brazil has registered most of the deaths. It is anticipated that the region will likely force a second lockdown, which will ultimately hamper the healthcare industry in the area. However, the outbreak of COVID–19 has critically affected the flow of medical services in the region. Post-coronavirus disease lockdown had a significant impact on sleep, as demonstrated by an increase in insomnia reports, particularly among women, but had no effect on adherence to positive airway pressure or self-reported sleep length. According to a poll, the vast majority claimed that in-laboratory sleep investigations were nearly discontinued, while a lesser percentage reported declines in home sleep apnea tests. There has been a significant increase in the usage of telemedicine, with the majority of respondents expecting this trend to continue in the future.

The South America sleep apnea diagnostics market is segmented on the basis of product, end user, and country. Based on product, the market is segmented into polysomnography (PSG) device, home sleep testing devices, oximeter, actigraphy monitoring device, and sleep apnea screening device. In 2021, polysomnography (PSG) device segment held the largest share in the market, and oximeter is expected to be the fastest growing segment during the forecast period. Further based on oximeter, the market is segmented into finger tip oximeter, handheld oximeter, wrist-worn oximeter, and tabletop oximeter. In 2021, finger tip oximeter segment held the largest share in the market, and it is also expected to be the fastest growing segment during the forecast period. Based on end user, the market is bifurcated into hospitals and sleep laboratories and home care settings. In 2021, hospitals and sleep laboratories segment held the largest share in the market, and home care settings is expected to be the fastest growing segment during the forecast period. Similarly Based on country the market is segmented into Brazil, Argentina, and Rest of South America. In 2021, Brazil held the largest share in the market, and it is also expected to be the fastest growing country during the forecast period.

ResMed, Inc.; Nihon Kohden Corporation LLC; SOMNOmedics GmbH; Cleveland Medical Devices Inc.; Koninklijke Philips N.V.; Natus Medical Incorporated; Itamar Medical Ltd.; and Compumedics Limited are among the leading companies in the South America sleep apnea diagnostics market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, Koninklijke Philips N.V. has launched Philips NightBalance, a prescription sleep position therapy device designed for patients with positional obstructive sleep apnea (OSA). The product is likely to non-inferior treatment to continuous positive airway pressure (CPAP) and demonstrate high adherence rates among positional OSA patients

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com